Projects funded by the NCN
Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple myeloma therapy – preclinical study .
2024/55/B/NZ7/02786
Keywords:
nanoparticiple angiogenesis endostatin angiostatin multiple myeloma
Descriptors:
- NZ7_14:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Pomorski Uniwersytet Medyczny w Szczecinie
woj. zachodniopomorskie
Principal investigator (from the host institution):
prof. Bogusław Bronisław Machaliński
Number of co-investigators in the project: 9
Call: OPUS 28 - announced on 2024-09-16
Amount awarded: 2 179 530 PLN
Project start date (Y-m-d): 2025-08-13
Project end date (Y-m-d): 2029-08-12
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.